TransMedics (TMDX) Enterprise Value (2018 - 2026)

TransMedics' Enterprise Value history runs 9 years deep, the most recent figure standing at -$461.7 million for Q1 2026.

• On a quarterly basis, Enterprise Value fell 48.87% year-over-year to -$461.7 million in Q1 2026; TTM through Mar 2026 was -$461.7 million, a 48.87% decrease from a year earlier, with the FY2025 full-year figure at -$488.4 million, down 45.07% from the prior year.
• Enterprise Value grew to -$461.7 million in Q1 2026 per TMDX's latest filing, from -$488.4 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$58.1 million in Q2 2022 and bottomed at -$582.2 million in Q2 2023.
• The 5-year median for Enterprise Value is -$350.2 million (2024), against an average of -$334.6 million.
• Across the five-year window, Enterprise Value surged 48.26% in 2022 and slumped 902.38% in 2023, its largest moves.
• Year by year, Enterprise Value stood at -$201.2 million in 2022, then sank by 96.25% to -$394.8 million in 2023, then gained by 14.73% to -$336.6 million in 2024, then plunged by 45.07% to -$488.4 million in 2025, then gained by 5.46% to -$461.7 million in 2026.
• Per Business Quant, the three latest TMDX Enterprise Value figures stand at -$461.7 million (Q1 2026), -$488.4 million (Q4 2025), and -$466.2 million (Q3 2025).